The induction of FOXM1 is driven by oncoproteins (Kras, E2F1, AKT) and repressed by tumor suppressors (miRNAs, RB, P53) in lung cancer, and the roles of FOXM1 in oncogenic pathways vary. Here, KRAS is linked to lung carcinoma.